Madrigal Pharmaceuticals (MDGL) EBITDA Margin (2010 - 2026)
Madrigal Pharmaceuticals' EBITDA Margin came in at -15.35% for Q2 2026, up 6.65 percentage points from -22.00% a year earlier and up 14.30 percentage points from the prior quarter.
Powered by 
Analysis
Madrigal Pharmaceuticals (MDGL) EBITDA Margin (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Madrigal Pharmaceuticals reported EBITDA Margin of -25.01%, up 34.81 percentage points year-over-year; for FY2025, it was -31.16%, up 244.63 percentage points from FY2024.
- Going back by year, EBITDA Margin was -275.78% in FY2024.
- The Q2 2026 figure represents the highest quarterly EBITDA Margin in data going back to Q3 2010.
- Year-over-year, EBITDA Margin has increased for five consecutive quarters, with an average year-over-year change of +262.83 percentage points over the last five quarters.
- Business Quant data shows MDGL's EBITDA Margin at -29.66% (Q1 2026), -18.44% (Q4 2025) and -39.55% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Madrigal Pharmaceuticals | 15.07 Bn | 11.32 Bn | - | -15.35% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15.35% |
| Mar 31, 2026 | -29.66% |
| Dec 31, 2025 | -18.44% |
| Sep 30, 2025 | -39.55% |
| Jun 30, 2025 | -22.00% |
| Mar 31, 2025 | -57.51% |
| Dec 31, 2024 | -64.49% |
| Sep 30, 2024 | -186.58% |
| Jun 30, 2024 | -1,108.55% |
| Mar 31, 2012 | -9,751.70% |
| Dec 31, 2011 | -290.62% |
| Sep 30, 2011 | -710.22% |
| Jun 30, 2011 | -857.39% |
| Mar 31, 2011 | -921.00% |
| Dec 31, 2010 | -195.74% |
| Sep 30, 2010 | -288.44% |
API Access
Madrigal Pharmaceuticals EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MDGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "MDGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MDGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();